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Abstract
Background: b2-microglobulin has been increasingly investigated as a diagnostic marker of kidney function and a
prognostic marker of adverse outcomes. To date, non-renal determinants of b2-microglobulin levels have not been well
described. Non-renal determinants are important for the interpretation and appraisal of the diagnostic and prognostic value
of any endogenous kidney function marker.
Methods: This cross-sectional analysis was performed within the framework of the www.seniorlabor.ch study, which
includes subjectively healthy individuals aged $60 years. Factors known or suspected to have a non-renal association with
kidney function markers were investigated for a non-renal association with serum b2-microglobulin. As a marker of kidney
function, the Berlin Initiative Study equation 2 for the estimation of the estimated glomerular filtration rate (eGFRBIS2) in the
elderly was employed.
Results: A total of 1302 participants (714 females and 588 males) were enrolled in the study. The use of a multivariate
regression model adjusting for age, gender and kidney function (eGFRBIS2) revealed age, male gender, and C-reactive
protein level to be positively associated with b2-microglobulin levels. In addition, there was an inverse non-renal
relationship between systolic blood pressure, total cholesterol and current smoking status. No association with markers of
diabetes mellitus, body stature, nutritional risk, thyroid function or calcium and phosphate levels was observed.
Conclusions: Serum b2-microglobulin levels in elderly subjects are related to several non-renal factors. These non-renal
factors are not congruent to those known from other markers (i.e. cystatin C and creatinine) and remind of classical
cardiovascular risk factors.
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Introduction
The glomerular filtration rate (GFR) is commonly regarded as
the most reliable global index of kidney function [1]. There are
two types of GFR values that differ based on the method used for
assessment: the measured GFR (mGFR) and the estimated GFR
(eGFR). The mGFR is commonly regarded as the most accurate
value for assessing kidney function [2]. The mGFR is determined
using exogenously administered substances, such as inulin, iohexol
and different isotopes. However, for practical reasons, this
parameter is rarely used in routine clinical practice [3]. To
approximate the mGFR, kidney function can be estimated using
kidney function equations, which are based on demographic data
and standardized measurements of serum analytes, such as
creatinine and cystatin C [4–7]. Concomitant reporting of the
eGFR together with the serum analyte concentrations has become
standard in many clinical laboratories [8].
Serum markers of kidney function have a reciprocal relationship
with the GFR, i.e., serum marker levels increase with decreasing
GFR and vice versa [2]. However, kidney function is not the only
determinant of a marker’s serum concentration. Because of
practical reasons, equations estimating eGFR account for the
most important but not all non-renal factors. Therefore, even if the
estimating equations for eGFR account for non-renal factors of
kidney function, other non-renal markers can still exert an
influence on the eGFR estimate.
Serum creatinine is influenced by age, gender, skin color and
ethnicity, body habitus, chronic illness, nutritional status and diet
[2,9,10]. The concentration of cystatin C is influenced by high-
dose glucocorticoid therapy, thyroid function and, to a lesser
degree, C-reactive protein (CRP), diabetes mellitus, systolic blood
pressure, age, smoking, gender and serum concentrations of other
analytes [11–16]. b2-microglobulin is a low-molecular-weight
protein (11.81 kDa) that is a component of the MHC 1 molecule
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present on all nucleated cells [17]. Because of the dependency of
its serum concentration on the GFR, b2-microglobulin is one of
the three classical low-molecular-weight protein markers of kidney
function, i.e., cystatin C, b-trace protein and b2-microglobulin
[18–22]. Inflammatory conditions, glucocorticoid therapy and
lymphoproliferative disease have been reported to be non-renal
determinants of the serum b2-microglobulin concentration; the
latter condition is also a rationale for the marker’s use as a tumor
marker in lymphoproliferative disease [23–27]. Currently, little is
known about other non-renal determinants. This issue merits
further study because b2-microglobulin is attracting increasing
interest as an endogenous serum marker of the GFR [28–30].
Because non-renal determinants are important for the interpre-
tation and appraisal of the diagnostic and prognostic value of any
endogenous kidney function marker, we aimed to study the
association of non-renal factors with the serum b2-microglobulin
concentration. Factors investigated for a non-renal association
with kidney function markers in other studies were chosen for the
present analysis.
Subjects and Methods
Study Population
The study participants were recruited from August 2009 to
November 2010 within the context of the Seniorlabor Study,
which is an ongoing investigation in the canton of Berne
(Switzerland) aimed at establishing appropriate reference intervals
of several analytes in the elderly (http://www.seniorlabor.ch).
Consecutive subjectively healthy elderly volunteers aged 60 years
and older were recruited, as previously described [31]. In brief, the
study participants were contacted through newspaper advertise-
ments, various clubs and associations that had high proportions of
healthy elderly members (e.g., alpine clubs and sports clubs) and
personal contacts of the collaborators of the study organization.
Participants with previously known diabetes mellitus, a diagnosis
of active neoplastic disease within the last 5 years, hospitalization
during the preceding 4 weeks, previously known thyroid disease
and those using glucocorticoid medications were not allowed to
participate in the study. This study was conducted in accordance
with the Declaration of Helsinki and approved by the canton’s
ethical committee board (Kantonale Ethikkommission Bern). All of
the participants provided written informed consent.
Data Collection
Each participant’s personal history was collected, anthropomet-
ric measurements, such as height and weight, were taken, and
blood pressure was measured in a sitting position after a 10-minute
rest period. Venous blood was drawn into S-MonovettesH
(Sarstedt, Sevelen, Switzerland) after an overnight fasting period.
The laboratory samples were processed (i.e., centrifuged, aliquoted
and analyzed or frozen at280uC) immediately after the blood was
drawn. The geriatric nutritional risk index (GNRI) score, modified
by Yamada et al. [32], was used as an index of nutritional status
[33,34]. The GNRI is calculated as follows:
GNRI~(1:489|albumin½g=L)z
41:7| bodyweight kgð Þ=ideal bodyweight kgð Þ½ ð Þ
In this equation, the ratio of the actual body weight to the ideal
body weight is set to one when the patient’s body weight exceeds
the ideal body weight. Ideal body weight was defined as the value
calculated from height and a BMI of 22 [32].
Laboratory Methods
The laboratory parameters were determined with various
analytical platforms. The b2-microglobulin concentration was
determined using an Immulite 2000 (Siemens, Zurich, Switzer-
land).
The IDMS-standardized creatinine (alkaline picrate method)
concentrations and albumin levels were determined on a Cobas
Integra 800 instrument (Roche Diagnostics, Rotkreuz, Switzer-
land). The cystatin C level was determined using a nephelometric
method on a Siemens ProSpec (Siemens, Zurich, Switzerland).
The results were standardized to the International Federation of
Clinical Chemistry and Laboratory Medicine standard, as
described by Inker et al. [5], and the estimated GFR was
determined using the Berlin Initiative Study equation 2 (BIS2),
which is the only equation that has been evaluated for estimating
GFR in elderly Caucasian subjects [7]. This equation accounts for
age, gender and standardized cystatin C and creatinine results; in
the elderly, it has been shown to outperform the original CKD-
EPI equation for estimating GFR [5,35]. However, this equation
has only undergone internal validation in the original study and so
far lacks external validation. The eGFRBIS2 is calculated as follows
[7]:
eGFRBIS2~767|cystatinC
{0:61xcreatinine{0:40
|age{0:57 |0:87,if femaleð Þ
The level of high-sensitivity CRP was determined on a Siemens
ProSpec (Siemens, Zurich, Switzerland). The concentrations of
albumin, calcium, glucose, phosphate and potassium were assayed
on a Cobas Integra 800 instrument (Roche Diagnostics, Rotkreuz,
Switzerland). The hemoglobin and white blood cell (WBC) count
were measured on a Sysmex XE-5000 hematology analyzer
(Sysmex, Horgen, Switzerland). The thyroid-stimulating hormone
(TSH) level was determined using an Architect 4000i (Abbott
Diagnostics, Baar, Switzerland), and the hemoglobin A1c (HbA1c)
level was determined using high-performance liquid chromatog-
raphy (BioRad D10, Pratteln, Switzerland). The inter-day
coefficients of variation, determined with commercially available
control materials, were as follows: 7.30% at 1.22 mg/L and 8.32%
at 3.18 mg/L for b2-microglobulin; 3.75% at 0.37 mg/L and
3.43% at 0.44 mg/L for cystatin C; 4.27% at 42 mmol/L and
1.96% at 556 mmol/L for creatinine; 3.7% at 24 g/L and 2.1% at
42 g/L for albumin; 6.7% at 0.64 mmol/L and 2.4% at
2.21 mmol/L for phosphate; 2.0% at 2.53 mmol/L and 2.0% at
3.25 mmol/L for calcium; 2.2% at 3.5 mmol/L and 1.9% at
6.5 mmol/L for glucose; 5.38% at 5.8 g/L and 4.87% at 44.7 g/L
for CRP; 2.95% at 0.78 nU/L and 3.29% at 27.7 mU/L for
TSH; and 2.88% at 5.7% and 2.38% at 10.8% for HbA1c.
Statistical Analysis
The data are presented as medians and interquartile ranges
(IQRs) or mean 6 standard deviation, depending on the
assessment with the Pearson d’Agostino test. To determine
whether the b2-microglobulin concentrations were associated
with non-renal factors, linear regression models were used. As
candidate predictors, variables known to be independently from
kidney function being associated with other endogenous markers
of GFR [12], were investigated: such as age, gender, BMI, height,
weight, systolic and diastolic blood pressure, self-reported hyper-
tension, known cardiovascular disease, known musculoskeletal
problems, GNRI, current smoking, blood urea nitrogen, hemo-
globin, white blood cell count, glucose, hemoglobin A1c,
Non-Renal Associations of Beta-2-Microglobulin
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potassium, sodium, total cholesterol, triglycerides, calcium, phos-
phate, albumin, CRP, and TSH. Continuous variables were log
transformed if they were not normally distributed. These models
considered b2-microglobulin as a dependent variable and other
clinical and laboratory parameters as independent variables.
Unadjusted associations were calculated. Furthermore, these
associations were adjusted for kidney function, as assessed with
eGFRBIS2, age and gender. Finally, a model employing all of the
significant predictors in the aforementioned adjusted associations
was fit. For the multivariate models, partial correlation coefficients
rpartial were calculated. These coefficients estimated the correlation
of each variable with log b2-microglobulin, adjusted for the effect
of the other variables in the model. The comparisons between the
two groups were performed with the Mann-Whitney U-test.
Proportions were compared using the chi-square test. For all
comparisons, P values ,0.05 were considered to be significant. p-
values up to 0.20 are reported numerically, whereas p-values .0.2
are reported as not significant (n.s.). All calculations were
performed with MedCalc software version 12.2.1 (MedCalc
software, Mariakerke, Belgium).
Results
A total of 1302 individuals (714 female/588 male) with a
median age of 72 years and an IQR of (66,78) were included in the
study. All participants were of Caucasian descent. The detailed
characteristics of the study population are given in Table 1. The
median eGFRBIS2 was 73 ml/min/1.73 m
2 (62,83). An eGFR-
BIS2,60 ml/min/1.73 m
2 was present in 20.20% of the partici-
pants, whereas an eGFRBIS2.90 ml/min/1.73 m
2 was found in
9.83%. There were no significant gender-specific differences in
age, systolic and diastolic blood pressure, eGFRBIS2, albumin,
HbA1c, potassium or CRP. However, female participants had a
significantly lower BMI, weight, height, GNRI score, smoking
prevalence, cystatin C level, creatinine level, b2-microglobulin
level, blood urea nitrogen level, hemoglobin level, fasting glucose
level and WBC count. Males had lower calcium and phosphate
levels than females. Although statistically significant, these gender-
specific differences, with the exception of serum creatinine and
hemoglobin levels, were small. The Spearman rank correlation
coefficient of the reciprocal of b2-microglobulin and eGFRBIS2
was 0.70 (P,0.001). The relationship between the inverse b2-
microglobulin levels and eGFRBIS2 is given in Figure 1. Table 2
shows the regression coefficients together with standard errors
relating the log b2-microglobulin with different predictor vari-
ables. As expected, the univariate analysis of b2-microglobulin
levels and the chosen predictors hypothesized to be associated with
kidney function markers revealed a significant relationship for a
majority of predictors.
Non-renal factors associated with log b2-microglobulin were
assessed by adjusting the linear regression models for log age,
gender and log eGFRBIS2. Fitting these models revealed that age,
gender, systolic blood pressure, current smoking, potassium level,
total cholesterol, CRP level and WBC count were non-renal
predictors of b2-microglobulin concentrations. b2-microglobulin
increased with age, male gender, CRP levels and WBC levels. In
contrast, b2-microglobulin levels were inversely associated with
increasing systolic blood pressure, total cholesterol and current
smoking status. There did not seem to be a non-renal association
between markers of diabetes mellitus, body stature, nutritional
risk, thyroid function or calcium and phosphate levels and b2-
microglobulin levels.
Finally a model incorporating all significant predictors from the
aforementioned adjusted models was fitted, as shown in Table 3.
With the exception of potassium and WBC levels, all predictors
remained significant. The strongest association of b2-microglobu-
lin concentrations, as obtained by partial correlation, was seen
with kidney function. Weaker associations were seen with, age,
gender, CRP, total cholesterol, systolic blood pressure, and
smoking.
Discussion
This cross-sectional study in a population of subjectively health
elderly participants predominantly having mild to moderate
impairment of kidney function [1] provides evidence that the
b2-microglobulin concentration, independent of kidney function,
is associated with several factors, such as systolic blood pressure,
age, gender, total cholesterol, markers of inflammation and
smoking status. There were no relationships between b2-micro-
globulin and several non-renal factors known to be associated with
other kidney function markers, such as cystatin C and creatinine.
To our knowledge, this is the first study to investigate these
associations in models adjusting for kidney function.
Understanding the non-renal determinants of an endogenous
serum marker of kidney function is important because this
understanding allows for the identification of variables to be used
in the equations to transform a serum value into the corresponding
eGFR [10]. The introduction of these variables into the equations
improves both the precision and the accuracy of GFR estimates.
Furthermore, information on the non-renal determinants of
kidney function markers might also help to elucidate the
relationship between the serum concentrations of these markers
and clinical outcomes of interest, such as mortality and cardio-
vascular or renal incidents [10,29,36]. Accordingly, our study
provides evidence that age and gender should be considered as
predictors in regard to the evaluation of an equation for estimating
GFR from b2-microglobulin [20]. This is analogous to the GFR
estimation equations based on creatinine and/or cystatin C
measurements [6,37]. Adding the other significant parameters
CRP, total cholesterol, systolic blood pressure, and smoking status
into a kidney function equation, although increasing complexity of
the equation, is not expected to substantially increase accuracy of
kidney function estimates. However, in patients with current
smoking, marked inflammation, marked hypertension, and
Figure 1. The relationship between b2-microglobulin and
eGFRBIS2.
doi:10.1371/journal.pone.0072073.g001
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marked hypercholesterolemia, a kidney function equation based
on b2-microglobulin should be used with caution.
Interestingly, we did not find non-renal associations between
b2-microglobulin and body weight or body mass index (BMI).
This finding is in line with the findings described by Filler et al.
[38], who investigated 216 pediatric urology patients aged 0.8–18
years. No changes in b2-microglobulin with age and weight were
observed in these children. To our knowledge, however, this is the
first investigation that reports the absent association between
weight and b2-microglobulin in adults. We cannot offer an
explanation for this absent relationship, which is in contrast to the
findings of another low-molecular-weight protein, cystatin C,
having been described to have a non-renal relationship with
weight and BMI [12]. Creatinine, in contrast to cystatin C, has
been shown to depend on dietary protein intake [10]. Our
investigation used nutritional risk as a surrogate marker of protein
intake and did not find a relationship between nutritional risk and
b2-microglobulin levels. This is in line with the findings of Viberti
et al. [39], who did not find a relationship between food intake
and b2-microglobulin levels in 12 patients with diabetes mellitus.
Serum b2-microglobulin levels can increase as an acute phase
reactant in several diseases. Accordingly, increased levels have
been found in autoimmune diseases, such as systemic lupus
erythematosus, rheumatoid arthritis and Sjo¨gren’s syndrome, as
well as in lymphoproliferative and infectious diseases [23,25,40–
42]. The present investigation found that the association between
inflammatory markers (CRP and WBC) and b2-microglobulin was
independent of kidney function, even at normal levels. Inflamma-
tory markers have also been reported to be associated with cystatin
C but not with serum creatinine [12]. This additional association
with inflammatory states could be one of the reasons why risk
prediction for cardiovascular events and mortality is better with
cystatin C and b2-microglobulin than with creatinine alone
[29,43,44]. Further, when looking at the significant predictors of
b2-microglobulin concentrations, it becomes apparent, that all
these predictors also represent major cardiovascular risk factors
(i.e. decreased kidney function, cholesterol, smoking, age, gender,
Table 1. Demographics of the study cohort stratified according to gender.
Variable
Female (n=714)
Median (IQR)/N [%]
Male (n=588)
Median (IQR)/N (%) p
Age (years) 72 (66,79) 71 (66,78) n.s.
BMI (kg/m2) 24.5 (22.1, 26.9) 25.4 (23.6,28.0) ,0.001
Height (cm) 163 (159,169) 174 (170,178) ,0.001
Weight (kg) 64 (58,72) 77 (71,86) ,0.001
Systolic blood pressure (mmHg) 146 (130,161) 148 (133,164) 0.09
Diastolic blood pressure (mmHg) 90 (80,100) 90 (80,99) n.s.
Self-reported Hypertension (N) 279 (39.08) 256 (43.54) 0.12
Cardiovascular disease (N) 91 (12.75) 83 (14.12) n.s.
Musculosceletal disease (N) 93 (13.03) 55 (9.35) 0.04
HbA1c $6.5% (N) 47 (6.58) 62 (10.54) 0.01
GNRI score 106 (103,108) 106 (103,109) 0.03
Current smoker (N) 37 (5.18) 63 (10.17) ,0.001
eGFRBIS2 (ml/min/1.73 m
2) 72 (62,82) 73 (63,82) 0.11
eGFRCKD-EPI2012 (ml/min/1.73 m
2) 81 (69. 92) 83 (71,93) 0.15
b2-microglobulin (mg/L) 1.7 (1.5,2.1) 1.8 (1.5,2.2) 0.05
Cystatin C (mg/L) 0.87 (0.78,1.00) 0.91 (0.82,1.03) ,0.001
Creatinine (mg/dl) 0.75 (0.67,0.85) 0.96 (0.86,1.07) ,0.001
Blood urea nitrogen (mmol/L) 5.2 (4.5,6.1) 5.9 (4.9,7.0) ,0.001
Hemoglobin (g/L) 137 (131,142) 149 (142,155) ,0.001
Potassium (mmol/L) 4.5 (4.2,4.7) 4.5 (4.3,4.7) n.s.
Glucose (mmol/L) 5.1 (4.8,5.5) 5.4 (5.1,5.8) ,0.001
Total cholesterol (mmol/L) 6.1 (5.3,6.8) 5.4 (4.7,6.0) ,0.001
Triglycerides (mmol/L) 1.2 (0.9,1.6) 1.2 (0.9,1.7) n.s.
Calcium (mmol/L) 2.40 (2.34,2.46) 2.37 (2.30,2.42) ,0.001
Phosphate (mmol/L) 1.1860.14 1.0360.14 ,0.001
Albumin (g/L) 43 (42,45) 43 (42,45) n.s.
HbA1c (%) 5.8 (5.6,6.1) 5.8 (5.6,6.1) n.s.
CRP (mg/L) 1.30 (0.68,2.50) 1.29 (0.71,2.33) n.s.
TSH (U/L) 1.86 (1.25,2.57) 1.68 (1.22,2.44) 0.07
WBC (cells/ml) 5.3 (4.6,6.3) 5.7 (4.9,6.7) ,0.001
Values are shown as medians with IQRs in parentheses for continuous variables or numbers and percentages in brackets for categorical variables.
doi:10.1371/journal.pone.0072073.t001
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increased high sensitive CRP, systolic blood pressure). Interest-
ingly, not all these major cardiovascular risk factors exhibit an
uniform positive non-renal association with b2-microglobulin
concentrations. Some of them were also inversely correlated
illustrating opposing effects of the different non-renal determinants
of b2-microglobulin concentrations. Despite these opposing
effects, however, other studies found b2-microglobulin concentra-
tions to be significant non-renal predictors of cardiovascular
outcomes, renal outcomes, and mortality [29,36].
Our study identified smoking to be a non-renal factor associated
with b2-microglobulin levels. Our multivariate model indicates
that this association is independent from inflammation. This is in
contrast to the report by Juraschek et al. [30], who did not find
increased b2-microglobulin levels in smokers compared to non-
smokers in the NHANES III survey. This finding, however, was
obtained from logistic regression modeling, which did not adjust
for kidney function markers. These somehow discrepant findings
add to the controversy on current smoking as a non-renal factor
associated with cystatin C. In the PREVEND cohort, Knight et al.
[15] found a significant independent association between smoking
and cystatin C, while White et al. [45] did not observe such a
relationship in a cohort of kidney transplant patients. The non-
renal association of systolic but not diastolic blood pressure with
b2-microglobulin levels has not been described to our knowledge.
This finding parallels the finding of the non-renal association of
systolic blood pressure with cystatin C [12].
Non-renal determinants are important for the interpretation
and appraisal of the diagnostic and prognostic value of any
endogenous kidney function marker. For example, it does not
make much sense to assess kidney function with a creatinine-based
GFR estimate in patients with reduced muscle mass due to spinal
cord injury. For this purpose, cystatin C has been shown to have
better diagnostic characteristics than serum creatinine [46].
Conversely, it might be useless to assess kidney function using
cystatin C-based GFR estimates in patients with thyroid disease
and exposure to high doses of glucocorticoids [14,47]. While our
findings suggest that b2-microglobulin serves as an alternative
protein marker to cystatin C in patients with thyroid disease, it
would be useless in patients on glucocorticoids [26]. Table 4
summarizes different non-renal factors and their associations with
Table 2. Coefficients and standard errors from linear regression analysis assessing the relationship between log b2-microglobulin
concentrations as dependent variable and several independent variables are shown.
Unadjusted Adjusted for log eGFRBIS2, log age and gender
Variable Coeff. Std. error p Coeff. Std. error p rpartial
Log age (years) 1.175 0.065 ,0.001 20.254 0.061 ,0.001 20.11
Male gender 0.016 0.007 0.02 0.023 0.004 ,0.001 0.14
Log eGFRBIS2 (ml/min/1.73 m
2) 20.969 0.023 ,0.001 21.054 0.030 ,0.001 20.70
Log BMI (kg/m2) 0.114 0.056 0.04 20.048 0.037 0.19 –
Log height (cm) 20.125 0.154 n.s. 20.070 0.135 n.s. –
Log weight (kg) 0.053 0.045 n.s. 20.047 0.034 0.17 –
Log systolic blood pressure (mmHg) 20.082 0.053 0.12 20.091 0.035 0.01 20.07
Log diastolic blood pressure (mmHg) 20.212 0.055 0.001 20.045 0.036 0.20 –
Self-reported Hypertension 0.061 0.007 ,0.001 0.009 0.005 0.06 –
Cardiovascular disease 0.084 0.010 ,0.001 0.009 0.007 0.16 –
Musculosceletal disease 0.021 0.011 0.06 20.007 0.007 n.s. –
Log GNRI score 21.267 0.199 ,0.001 20.106 0.132 n.s. –
Current smoker 20.036 0.014 0.01 20.020 0.009 0.03 20.06
Log blood urea nitrogen (mmol/L) 0.466 0.026 ,0.001 0.018 0.023 n.s. –
Log hemoglobin (g/L) 20.361 0.094 ,0.001 20.120 0.070 0.09 –
Log potassium (mmol/L) 0.266 0.097 0.006 20.131 0.062 0.05 –
Log glucose (mmol/L) 0.148 0.056 0.008 20.005 0.037 n.s. –
Log total cholesterol (mmol/L) 20.294 0.038 ,0.001 20.164 0.026 ,0.001 20.17
Log triglycerides (mmol/L) 0.085 0.018 ,0.001 0.000 0.012 n.s. –
Log calcium (mmol/L) 20.035 0.195 n.s. 20.187 0.126 0.14 –
Phosphate (mmol/L) 20.031 0.021 0.15 20.011 0.015 n.s. –
Log albumin (g/L) 20.868 0.125 ,0.001 20.035 0.084 n.s. –
Log HbA1c (%) 0.569 0.096 ,0.001 0.036 0.064 n.s. –
Log CRP (mg/L) 0.074 0.007 ,0.001 0.031 0.005 ,0.001 0.17
Log TSH (U/L) 0.010 0.012 n.s. 20.001 0.008 n.s. –
Log WBC (cells/ml) 0.217 0.033 ,0.001 0.049 0.022 0.02 0.06
The coefficients for log age, male gender, and eGFRBIS2, the coefficients were obtained from a model incorporating log eGFRBIS2, log age and gender as independent
variables and log b2-microglobulin as dependent variable. This model explained 60% of the variability of log b2-microglobulin. The partial correlation coefficients rpartial
are given for significant predictors in the adjusted models and represent the correlation of each variable with log b2-microglobulin, adjusted for the effect of the other
variables in the model (i.e. log eGFRBIS2, log age, and gender). P denotes the level of significance for each specific relationship.
doi:10.1371/journal.pone.0072073.t002
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serum levels of creatinine, cystatin C and b2-microglobulin. These
results could lead to the patient-specific use of several kidney
function markers. In a hypothetical patient with paraplegia and
untreated thyroid disease, neither cystatin C nor creatinine would
be expected to allow for unbiased kidney function assessment. b2-
microglobulin could be the appropriate kidney marker for this
patient.
However, more studies are necessary before the b2-micro-
globulin can be used as a kidney function marker in clinical
routine. First, b2-microglobulin methods should be standard-
ized [48,49]. Second, a GFR estimating equation for standard-
ized b2-microglobulin should be developed. To our knowledge,
the equation by Donadio et al. [20] is the only GFR estimate
based on b2-microglobulin that is currently available. This
equation is based on a different assay for measuring the
estimated GFR (Abbott Axsym) than the one employed in our
study. Using the results from our method together with
Donadio’s equation would lead to erroneous GFR estimates,
as observed in Figure S1. As long as b2-microglobulin is not
standardized, each assay should employ its corresponding GFR
estimation equation [50].
Our study has several limitations. First and most importantly,
we estimated GFR and did not use a reference method directly
measuring GFR by means of exogenous substances. Direct GFR
measurement does not undergo non-renal modification and
allows for definitive answers. Logistically, it would have been
impossible for us to perform direct GFR measurements in such a
large population. Although we did not use a reference method
for GFR assessment, we used the most accurate routine methods
currently available, which rely on two serum markers and
represent the appropriate methods for the population under
study [7]. Furthermore, the first studies on non-renal factors
associated with cystatin C levels did not employ reference
methods for GFR assessment (e.g., glucocorticoid therapy,
thyroid function, weight, CRP, gender and age) [14,15,47,51].
These findings could be confirmed in studies employing
reference methods for GFR assessment [12]. In this respect,
we believe that our investigation adds important information on
another endogenous kidney function marker. Second, the
generalizability of our findings is hampered by the fact that
we exclusively examined Caucasian subjects and that our
participants were elderly. Our findings cannot be extrapolated
to the general population. Nevertheless, it is in the elderly
population, where the importance of kidney function estimation
increases, in order to prevent errors in clinical management,
especially regarding drug dosing or application of contrast
media. Third, it may also be possible that we missed important
non-renal factors. In summary, however, we believe that these
limitations do not invalidate our findings.
Conclusions
The serum concentration of b2-microglobulin was demon-
strated to be associated with several non-renal factors, such as
age, gender, CRP, cholesterol, systolic blood pressure, gender
and current smoking. All these factors represent major cardio-
vascular risk factors. Our findings were derived from elderly
individuals and cannot be extrapolated to the general population.
Elderly patients, however, represent a collective with frequent
need for determination of kidney function. Several factors
affecting serum cystatin C levels, such as thyroid dysfunction,
weight and hemoglobin concentrations, did not exhibit a non-
renal association with b2-microglobulin. Information on non-
renal factors associated with b2-microglobulin will allow for the
identification of clinical scenarios where other kidney function
Table 3. A multivariate model including all the significant
predictors of log b2-microglobulin concentrations from table 2
is shown.
Variable Coeff Std. errorp rpartial
Log age (years) 20.241 0.064 ,0.001 20.11
Male gender 0.015 0.004 0.002 0.09
Log eGFRBIS2 (ml/min/1.73 m
2) 21.009 0.030 ,0.001 20.68
Log systolic blood pressure
(mmHg)
20.064 0.035 0.03 20.06
Current smoker 20.022 0.009 0.02 20.07
Log total cholesterol (mmol/L) 20.140 0.026 ,0.001 20.15
Log CRP (mg/L) 0.029 0.005 ,0.001 0.16
Log WBC (cells/ml) 0.009 0.022 n.s. –
Log potassium (mmol/L) 20.080 0.061 n.s. –
This model explains 62% of the variability of log b2-microglobulin
concentrations and is thus not much more predictive than a model containing
log eGFRBIS2, log age, and gender as independent variables. The partial
correlation coefficients rpartial are given for significant predictors in the model
and represent the correlation of each variable with log b2-microglobulin,
adjusted for the effect of the other variables in the model.
doi:10.1371/journal.pone.0072073.t003
Table 4. Non-renal factors associated with serum levels of
endogenous kidney function markers.
Variable Creatinine Cystatin C
b2-
Microglobulin
Age + [12] + [12] +
Gender + [12] + [12] +
Ethnicity + [12] + [12] 2 [30]
Diabetes/HbA1c/Glucose2 [12] + [12] 2
Systolic blood pressure 2 [12] + [12] +
Weight/BMI + [12] + [12] 2
Nutritional status/GNRI + [10] 2 [10] 2
Lymphoproliferative
disease
2 [52] 2 [24] + [23]
Current smoking ? +/2 [15,45] +
Glucocorticoid therapy 2 [45] + [14,53] + [26]
Calcineurin inhibitors 2 [45] +/2 [45,54] ?
Thyroid function 2 [55] + [47] 2
Potassium 2 [12] 2 [12] +
Hemoglobin 2 [12] + [12] 2
Serum urea nitrogen + [12] 2 [12] 2
WBC count + [12] +[12] +
CRP 2 [12] + [12] +
Phosphate + [12] 2 [12] 2
Calcium 2 [12] + [12] 2
Cholesterol 2 [12] 2 [12] +
Data were collected from the present study or the literature. References to
other studies are given in brackets. Not all studies employed multivariate
adjustments for evaluating non-renal associations. The method of assessing
kidney function varied between the different studies.
doi:10.1371/journal.pone.0072073.t004
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markers, such as cystatin C and creatinine, are unable to provide
adequate answers.
Supporting Information
Figure S1 Introducing b2-microglobulin values from the
Siemens Immulite into the equation by Donadio [20] leads to
erroneous GFR estimates that systematically underestimate kidney
function. A Bland-Altman plot is shown. This method assesses the
agreement between two measurements of the same variable. Bias
denotes the mean of all differences, whereas the limits of
agreement are assessed with 61.96 standard deviations around
the bias. The mean bias is 210.1 ml/min/1.73 m2. The limits of
agreement are232.3 to +12.2 ml/min/1.73 m2. The eGFRBIS2 is
used as a reference method for determining kidney function.
(TIF)
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